Add this topic to your myFT Digest for news straight to your inbox
French pharma group steps up efforts to become global force in oncology
Big pharma companies are defending payments to producers of low-cost rivals, says Andrew Jack
Kester Eddy on how a Hungarian generic drugs company deals with tough rules
Damning report reveals series of failures
International Edition